Skip to main content

Find Clinical Trials

Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,038 public trials 1,176 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck

NCT00581360

Conditions: Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +4 more
Locations: UPMC Cancer Center - Teramana Cancer Center - Steubenville Steubenville, Ohio, United States

UPMC Cancer Center - Beaver Beaver, Pennsylvania, United States

UPMC Cancer Center - Clairton Clairton, Pennsylvania, United States

UPMC Cancer Center - Arnold Palmer Pavilion - Greensburg Greensburg, Pennsylvania, United States

View all 21 locations

View Trial Details

Completed

A Safety, Tolerability, and Pharmacokinetics Study of Onartuzumab as Single Agent or in Combination With Sorafenib in Participants With Advanced Hepatocellular Carcinoma

NCT01897038

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Sarasota, Florida, United States

Baltimore, Maryland, United States

New York, United States

Nashville, Tennessee, United States

View Trial Details

Completed

A Study of Capecitabine (Xeloda) and Peginterferon Alfa-2a (Pegasys) in Treatment-Naive Participants With Advanced Liver Cancer

NCT02576964

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Beijing, China

Guangzhou, China

Kueishan, Taiwan

Tainan, Taiwan

View Trial Details

Completed

A Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular Carcinoma

NCT01308723

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Singapore

Singapore

View Trial Details

Completed

An Observational Study of Avastin (Bevacizumab) and Interferon Alpha 2a in Patients With Metastatic Renal Cell Cancer (VERA)

NCT01392729

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Cluj-Napoca, Romania

View Trial Details

Completed

Factors Influencing the 3-Year Recurrence of Liver Carcinoma After Surgery

NCT02941861

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations: Not specified

View Trial Details

Completed

Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors

NCT00804336

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +18 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Duration of Treatment With Tyrosine Kinase Inhibitors in the Treatment of Metastatic Renal Cell Carcinoma

NCT01585974

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Many Locations, Turkey (Türkiye)

View Trial Details

Completed

Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib

NCT00812175

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Many Locations, Alabama, United States

Many Locations, Arizona, United States

Many Locations, Arkansas, United States

Many Locations, California, United States

View all 75 locations

View Trial Details

Completed

Effect of tDCS on Chronic Abdominal Visceral Pain in HCC Patients

NCT02928237

Conditions: Abdominal Pain, Adenocarcinoma, Agnosia, +18 more
Locations: Not specified

View Trial Details